Stephen M Krane1. Show Affiliations » 1. Harvard Medical School and Massachusetts General Hospital, Center for Immunology and Inflammatory Diseases, Department of Medicine, Boston, MA 02129, USA. krane.stephen@mgh.harvard.edu
Abstract
Entities: Chemical Disease Species
Mesh： See more » Administration, OralAdultBone Density Conservation Agents/therapeutic useDiphosphonates/administration & dosageDiphosphonates/therapeutic useDose-Response Relationship, DrugDouble-Blind MethodEtidronic Acid/administration & dosageEtidronic Acid/analogs & derivativesEtidronic Acid/therapeutic useFollow-Up StudiesHumansImidazoles/administration & dosageImidazoles/therapeutic useInfusions, IntravenousOsteitis Deformans/drug therapyRisedronic AcidTreatment OutcomeZoledronic Acid
Substances： See more » Bone Density Conservation AgentsDiphosphonatesImidazolesZoledronic AcidRisedronic AcidEtidronic Acid
Year: 2006 PMID： 16932682 DOI： 10.1038/ncprheum0158
Source DB: PubMed Journal: Nat Clin Pract Rheumatol ISSN： 1745-8382